Photoacoustic Imaging (Clinical)

Photoacoustic imaging (PAI) is a non-ionizing hybrid modality combining the spectroscopic specificity of optical imaging with the spatial resolution and depth of ultrasound. Short laser pulses (nanosecond range) are delivered to tissue, where light-absorbing molecules (oxy- and deoxyhemoglobin, melanin, lipid, water, exogenous contrast) undergo thermoelastic expansion and generate acoustic waves detected by ultrasound transducers; multispectral acquisition allows quantification of tissue chromophores.

Clinical PAI implementations include handheld linear-array systems combined with conventional ultrasound (multispectral optoacoustic tomography, MSOT), photoacoustic mammography for breast cancer characterization (vascular density, oxygen saturation), photoacoustic dermoscopy for melanoma thickness measurement and vascular malformation mapping, photoacoustic-guided peripheral nerve blocks, thyroid nodule evaluation, and intraoperative oncologic margin assessment. Functional imaging applications include sentinel lymph node mapping with methylene blue, indocyanine green, or nanoparticle agents.

Strengths include high optical contrast, real-time imaging, lack of ionizing radiation, ability to differentiate oxygenated and deoxygenated hemoglobin, and compatibility with conventional ultrasound. Limitations include depth restricted by light penetration (typically up to 4-5 cm), motion sensitivity, complex spectral processing, and laser safety considerations (ANSI standards) that require trained operators and protective eyewear; widespread adoption is limited by cost, training, and standardization.